Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
09/08/2022 | 184.74% | Cantor Fitzgerald | → $1.5 | Initiates Coverage On | → Overweight |
08/10/2022 | 469.48% | HC Wainwright & Co. | $4 → $3 | Maintains | Buy |
05/26/2021 | 659.3% | HC Wainwright & Co. | → $4 | Initiates Coverage On | → Buy |
Asensus Surgical Questions & Answers
The latest price target for Asensus Surgical (AMEX: ASXC) was reported by Cantor Fitzgerald on September 8, 2022. The analyst firm set a price target for $1.50 expecting ASXC to rise to within 12 months (a possible 184.74% upside). 2 analyst firms have reported ratings in the last year.
The latest analyst rating for Asensus Surgical (AMEX: ASXC) was provided by Cantor Fitzgerald, and Asensus Surgical initiated their overweight rating.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Asensus Surgical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Asensus Surgical was filed on September 8, 2022 so you should expect the next rating to be made available sometime around September 8, 2023.
While ratings are subjective and will change, the latest Asensus Surgical (ASXC) rating was a initiated with a price target of $0.00 to $1.50. The current price Asensus Surgical (ASXC) is trading at is $0.53, which is within the analyst's predicted range.